The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study
- 15 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 187 (8) , 1598-1612
Abstract
Inorganic arsenic exposure is ubiquitous, and both exposure and interindividual differences in its metabolism have been associated with cardiometabolic risk. However, the associations of arsenic exposure and arsenic metabolism with the metabolic syndrome (MetS) and its individual components are relatively unknown. We used Poisson regression with robust variance to evaluate the associations of baseline arsenic exposure (urinary arsenic levels) and metabolism (relative percentage of arsenic species over their sum) with incident MetS and its individual components (elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension, and elevated fasting plasma glucose) in 1,047 participants from the Strong Heart Family Study, a prospective family-based cohort study in American Indian communities (baseline visits were held in 1998–1999 and 2001–2003, follow-up visits in 2001–2003 and 2006–2009). Over the course of follow-up, 32% of participants developed MetS. An interquartile-range increase in arsenic exposure was associated with a 1.19-fold (95% confidence interval: 1.01, 1.41) greater risk of elevated fasting plasma glucose concentration but not with other individual components of the MetS or MetS overall. Arsenic metabolism, specifically lower percentage of monomethylarsonic acid and higher percentage of dimethylarsinic acid, was associated with higher risk of overall MetS and elevated waist circumference but not with any other MetS component. These findings support the hypothesis that there are contrasting and independent associations of arsenic exposure and arsenic metabolism with metabolic outcomes which may contribute to overall diabetes risk.Keywords
Funding Information
- National Institute of Environmental Health Sciences (1F31ES027796-01, 5T32ES007141-33, R01ES025216, 5P30ES009089, P42ES010349)
- National Heart, Lung, and Blood Institute (R01-HL090863, R01-HL109315, R01HL109301, R01HL109284, R01HL109282, R01HL109319, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65520, U01-HL65521)
This publication has 78 references indexed in Scilit:
- Association of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS)Environmental Health Perspectives, 2017
- Diabetes in Native Americans: elevated risk as a result of exposure to polychlorinated biphenyls (PCBs)Reviews on Environmental Health, 2016
- Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, MexicoEnvironmental Health Perspectives, 2016
- Association Between Exposure to Low to Moderate Arsenic Levels and Incident Cardiovascular DiseaseAnnals of Internal Medicine, 2013
- Evaluation of the Association between Arsenic and Diabetes: A National Toxicology Program Workshop ReviewEnvironmental Health Perspectives, 2012
- Arsenic Exposure and Cardiovascular Disease:An Updated Systematic ReviewCurrent Atherosclerosis Reports, 2012
- The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescentsScience of The Total Environment, 2012
- Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of TaiwanEnvironment International, 2007
- Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and DiabetesDiabetes Care, 2007
- Ingested Inorganic Arsenic and Prevalence of Diabetes MellitusAmerican Journal of Epidemiology, 1994